Cargando…

1374. Carbapenem-Resistant Enterobacterales Infection in Children: Clinical and Molecular Data from a Prospective Multicenter Cohort Study

BACKGROUND: Carbapenem Resistant Enterobacterales (CRE) are an urgent public health threat. We describe the clinical and molecular epidemiology of CRE infection in a multicenter pediatric cohort. METHODS: Patients under 18 years of age with CRE positive cultures between April 30 2016 and August 31 2...

Descripción completa

Detalles Bibliográficos
Autores principales:	Fisher, Matthew, Dai, Weixiao, Doi, Yohei, Komarow, Lauren, Patel, Gopi, Revolinski, Sara, Huskins, W Charles, Fries, Bettina C, Banerjee, Ritu
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2020
Materias:	Poster Abstracts
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7776154/ http://dx.doi.org/10.1093/ofid/ofaa439.1556

Ejemplares similares

1029. Increased Mortality in Hospital-Onset Carbapenem-Resistant Enterobacterales Bloodstream Infections
por: Boutzoukas, Angelique E, et al.
Publicado: (2023)

P1374: RAMAN SPECTROSCOPY STUDIES OF IMMUNE RESPONSE ELEMENTS
por: Laskowska, Paulina, et al.
Publicado: (2023)

2136. In Vitro Activity of Nacubactam (OP0595) Combined with Cefepime against Carbapenem-resistant Enterobacterales Isolated in Japan
por: Yanagihara, Katsunori, et al.
Publicado: (2023)

Treatment Options for Carbapenem-resistant Gram-negative Bacterial Infections
por: Doi, Yohei
Publicado: (2019)

785. Distribution and Associated Mortality in Carbapenem-Resistant Gram-Negative Bacilli in Japan: A Multicenter Study From Multi-Drug Resistant Organisms Clinical Research Network (MDRnet)
por: Saito, Sho, et al.
Publicado: (2021)

Molecular characterization of clinical carbapenem-resistant Enterobacterales from Qatar
por: Abid, Fatma Ben, et al.
Publicado: (2021)

1374. Clinical Outcomes of Sepsis According to Race at University of Minnesota Medical Center
por: Meyer-Mueller, Cameron, et al.
Publicado: (2021)

1271. Efficacy and Safety of Cefiderocol and Best Available Therapy in Patients with Serious Infections Caused by Carbapenem-Resistant Gram-Negative Infections: Results of the Pathogen-Focused Phase 3 CREDIBLE-CR Study
por: Bassetti, Matteo, et al.
Publicado: (2020)

Comparison of sCIM and Other Phenotypic Detection Methods for Carbapenemase-Producing Enterobacterales
por: Hosoda, Takuya, et al.
Publicado: (2021)

Poor outcomes in both infection and colonization with carbapenem-resistant Enterobacterales
por: Howard-Anderson, Jessica R., et al.
Publicado: (2022)

Therapy of Infections due to Carbapenem-Resistant Gram-Negative Pathogens
por: Lee, Chang-Seop, et al.
Publicado: (2014)

857. Impact of Rapid Antibiotic Susceptibility Testing for Gram Negative Bacteremia Varies by Pathogen Type and Resistance: A Secondary Analysis of the RAPIDS GN Trial
por: Banerjee, Ritu, et al.
Publicado: (2023)

158. Intra- and Inter-hospital Epidemiology of Carbapenem-resistant klebsiella Pneumoniae in US Hospitals
por: Luterbach, Courtney, et al.
Publicado: (2020)

848. Trends of Carbapenem Resistance in Enterobacterales in the US Between 2015 and 2019
por: Marcella, Stephen, et al.
Publicado: (2020)

700. Ampicillin-Ceftriaxone Versus Ampicillin-Gentamicin for Definitive Therapy of Enterococcus faecalis Infective Endocarditis: A Propensity Score-Matched,Retrospective Cohort Analysis
por: Shah, Niyati H, et al.
Publicado: (2020)

1348. Indirect Standardization to Improve Comparison of Children’s Hospitals’ Antimicrobial Use
por: Wattier, Rachel, et al.
Publicado: (2020)

P1374: EASIX ASSESSED AT 1 YEAR AFTER ALLOGENIC HEMATOPOIETIC CELL TRANSPLANTATION PREDICTS THE ONSET OF SUBSEQUENT NON-RELAPSE MORTALITY
por: Takeda, R., et al.
Publicado: (2022)

Unusual community-associated carbapenem-resistant Acinetobacter baumannii infection, Pennsylvania, USA
por: Yassin, Mohamed H., et al.
Publicado: (2020)

1345. Impact of the COVID-19 Pandemic on Pediatric Ambulatory Antibiotic Use in an Academic Health System
por: Katz, Sophie E, et al.
Publicado: (2020)

1334. A Qualitative Assessment of Drivers of Antimicrobial Prescribing for Pediatric Patients in Diverse Ambulatory Settings
por: Spencer, Hillary, et al.
Publicado: (2020)

Molecular Epidemiology of Ceftriaxone-Nonsusceptible Enterobacterales Isolates in an Academic Medical Center in the United States
por: Tamma, Pranita D, et al.
Publicado: (2019)

Analysis of colistin resistance in carbapenem-resistant Enterobacterales and XDR Klebsiella pneumoniae
por: Bir, Raunak, et al.
Publicado: (2022)

358. Sociodemographic and clinical features of children and adolescents with SARS-CoV-2 infection in Nashville, Tennessee
por: Howard, Leigh, et al.
Publicado: (2020)

1374. Integrated Safety Summary of Omadacycline: A Novel Aminomethylcycline Antibiotic
por: Opal, Steven, et al.
Publicado: (2018)

Activity of mecillinam against carbapenem-resistant Enterobacterales
por: Emeraud, Cécile, et al.
Publicado: (2022)

Updates on the Status of Carbapenem-Resistant Enterobacterales in Lebanon
por: Fadlallah, Mahdi, et al.
Publicado: (2023)

733. Carbapenem-Resistant Enterobacterales (CRE) Colonization Prevalence in Botswana: an Antibiotic Resistance in Communities and Hospitals (ARCH) Study
por: Mannathoko, Naledi, et al.
Publicado: (2021)

405. Serum Antibody Responses Against Carbapenem-Resistant Klebsiella pneumoniae in Infected Patients
por: Banerjee, Kasturi, et al.
Publicado: (2019)

1247. Molecular Epidemiology of Multi-drug Resistant Klebsiella pneumoniae and K. quasipneumoniae in Qatar
por: Tsui, Clement, et al.
Publicado: (2021)

Serum Antibody Responses against Carbapenem-Resistant Klebsiella pneumoniae in Infected Patients
por: Banerjee, Kasturi, et al.
Publicado: (2021)

Screening for Metallo-Beta-Lactamases Using Non-Carbapenem Agents: Effective Detection of MBL-Producing Enterobacterales and Differentiation of Carbapenem-Resistant Enterobacterales
por: Takei, Kentarou, et al.
Publicado: (2023)

1443. Activity of Ceftazidime-Avibactam against Carbapemenase-negative Carbapenem-resistant Enterobacterales (CRE) Isolates from US Hospitals
por: Castanheira, Mariana, et al.
Publicado: (2020)

787. Clinical and Genomic Epidemiology of mcr-9 Containing Carbapenem-resistant Enterobacterales Isolates in Metropolitan Atlanta, 2012-2017
por: Babiker, Ahmed, et al.
Publicado: (2021)

1218. Activity of Meropenem-Vaborbactam and Comparator Agents Against Carbapenemase-Negative, Carbapenem-Resistant Enterobacterales from US Hospitals
por: Castanheira, Mariana, et al.
Publicado: (2021)

An Overview on Phenotypic and Genotypic Characterisation of Carbapenem-Resistant Enterobacterales
por: Rabaan, Ali A., et al.
Publicado: (2022)

2749. Impact of rapid carbapenemase identification on management of patients with carbapenem-resistant Enterobacterales infections
por: Burke, Elysia, et al.
Publicado: (2023)

First operation of the new I5 PU's: Run 422 - 1.3.74
por: Borer, J, et al.
Publicado: (1974)

CGH analysis in Colombian patients: findings of 1374 arrays in a seven-year study
por: García-Acero, Mary, et al.
Publicado: (2018)

1374. Foodborne disease outbreak at a delivery pizza and sushi restaurant, Kazakhstan, 2023
por: Ablimitova, Feruza, et al.
Publicado: (2023)

The carbapenem inoculum effect provides insight into the molecular mechanisms underlying carbapenem resistance in Enterobacterales
por: Cartagena, Alexis Jaramillo, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_mg5sqalceup06ucevp83sjgma7